Autologous haematopoietic stem cell transplantation for Crohn’s disease: A retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation

<strong>Background and Aims</strong> Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic option for patients with severe, treatment-refractory Crohn’s disease [CD]. The evidence base for AHSCT for CD is limited, with one randomised trial [ASTIC] suggesting benefi...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Brierley, CK, Castilla-Llorente, C, Labopin, M, Badoglio, M, Rovira, M, Ricart, E, Dierickx, D, Vermeire, S, Hasselblatt, P, Finke, J, Onida, F, Cassinotti, A, Satsangi, J, Kazmi, M, López-Sanromán, A, Schmidt, C, Farge, D, Travis, SPL, Hawkey, CJ, Snowden, JA
Natura:	Journal article
Lingua:	English
Pubblicazione:	Oxford University Press 2018

Autologous haematopoietic stem cell transplantation for Crohn’s disease: A retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation

Documenti analoghi